PROVENTAI N T E R N A T I O N A L

AGENDA ONCOLOGY

TRACK 2 - ONCOLOGY PRECISION MEDICINE / PERSONALISED MEDICINE

TRACK 1 - ONCOLOGYBIOMARKER DISCOVERY

TRACK 4 - ONCOLOGY ANTIBODY DISCOVERY

TRACK 3 - ONCOLOGY COMPANION DIAGNOSTICS

TRACK 6 - ONCOLOGYCLINICAL RESEARCH

TRACK 5 - ONCOLOGY IMMUNO-ONCOLOGY / CHECK POINT INHIBITORS

TRACK 8 - BIOINFORMATICS TRANSLATIONAL MEDICINE & INFORMATICS

TRACK 7 - BIOINFORMATICS GENOMICS

TRACK 10 - BIOINFORMATICS DATA INTEGRATION / DATA MINING

TRACK 9 - BIOINFORMATICS ARTIFICIAL INTELLIGENCE / MACHINE LEARNING

TRACK 12 - BIOINFORMATICSBIG DATA / DATA MANAGEMENT

TRACK 11 - BIOINFORMATICS DATA VISUALISATION

AGENDA BIOINFORMATICS

2019 ATTENDEES

SPONSORS

Click here to find out what our clients think about our Strategy Meetings

Fred Jacobs CEO TYG Oncology

Suzanne Saffie-Siebert CEO SiSaf

Alvaro Costa CEO Alkol Biotech

Soren Bregenholt CEO Macrophage Pharma

Paul Agapow Director Health Informatics AstraZeneca

Wolfgang Hackl Founder OncoGenomX

Steven Zimmer CEO EPICOMBI Therapeutics

Philip Beer Director Tessellex Ltd.

Marcelo Garcia Former Head of Medical SystemNovartis

Geert C. Mudde Founder and CSO TYG Oncology Ltd.

STANSTED

CONTRIBUTORS TO THE AGENDAOUR UNIQUE ONLINE MEETING FORMAT

Roundtable DiscussionsThese interactive and informal discussion groups are the hallmark of the meeting. The brightest minds in the industry are brought together in 60-minute sessions that enable participants from all over the world to share ideas, challenges and lessons learned.

Personalised AgendaEach delegate receives a personalised agenda with the roundtable discussions that you choose. You only attend sessions and meetings that fit your challenges and interests, ensuring your time spent on the online platform is focused and well-utilised.

One-to-one MeetingsThe most effective and time efficient way to assess potential partners at a strategic level. Gain access to our exclusive networking app to identify the people that you need to meet. The app will allow for instant anddirect messaging to organise online meetings during the dedicated time to most benefit you.

Strategic NetworkingStrategic networking opportunities form a key benefit of the meeting. Our new online format for building and strengthening alliances to make lasting connections that benefit you.

http://

2020JUNESTRATEGY 30thONLINE MEETINGBIOINFORMATICSBIOINFORMATICSONCOLOGYONCOLOGY

&

PROVENTAI N T E R N A T I O N A L

1

CO-HOST

GO TO MENU NEXT PAGEPREVIOUS PAGE

BIOINFORMATICSBIOINFORMATICSONCOLOGY

ONCOLOGY

ONTOFORCE empowers data-driven decisions, drives innovation and speeds up cycle time. We unlock and connect siloed data into a linked data fabric. This enables everyone to securely integrate, analyse, and extract data faster, bringing simplicity to complexity. With DISQOVER, ONTOFORCE developed an innovative, self-service, linked data platform that delivers trusted and timely insights for end users.

VISIT WEBSITE

VISIT WEBSITE

VISIT WEBSITE VISIT WEBSITE

VISIT WEBSITE

BioLizard is an expert team of data and bio-engineers dedicated to developing solutionsfor scientific research using bioinformatics, biostatistics, ML and AI. BioLizard transformsscientific data into highly valuable information, providing the necessary solutions to themost pressing questions. Our specialty is gathering a range of expertise tailored-made toour customers’ needs and developing innovative bioinformatics solutions required for even the most complex biological datasets. We implement up-to-date technological tools to assist our customers with their biological data integration, algorithm development, bioinformatics analyses, and pipeline implementation and automation. Importantly, ourprofessionals are also familiar with specific life science expertise.VISIT WEBSITE

PRO-PARTNERS

VISIT WEBSITE VISIT WEBSITEVISIT WEBSITE

Inteliquet is a leading provider of technology, insights and expertise for clinical research, patient treatment, and translational medicine strategies. Our sophisticated, proprietary platform can securely, accurately, and quickly aggregate and analyze healthcare data, helping to ensure clinical trials are designed more effectively, patients are matched to trials more rapidly and patient-care decisions are made using real-world evidence. Our team is passionate about ensuring that every patient—regardless of race, geography, age, sex, economic status, or stage of disease—has access to promising therapies as soon as they become available to help improve the care they, and future generations, receive.

Dotmatics delivers a ready-to-use platform to capture, register, share, collaborate, query, visualise and analyse all the information and knowledge generated in the modern, highly collaborative scientific industries. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualisation. The enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organisations, from discovery research to development and early manufacturing.

At Proventa Talent, we always look ahead to ensure that the service we deliver to you is second to none, both now and in the future. Proventa Talent based around our three key principles of commitment, intelligence and partnership ensures an unparalleled recruitment solution in the industry. We work with the leading talent in the field to offer a service of high quality, efficiency and transparency. In addition to this, our relationship with many organisations across the Life Sciences sector means that we are constantly developing our recruitment services to offer market-leading solutions including Contingency, Executive Search, Contract and fully integrated Recruitment Process Outsourcing to suit your short, medium and long term needs.

SPONSORS&

PROVENTAI N T E R N A T I O N A L

2 GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

ROUND TABLE TOPIC CONFIRMED FOR SPONSOR

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION

KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION

Biomarker discovery and validation: genomics and

beyond

Machine learning informed biomarker selection using multi-omics integration.

Extracellular RNA biomarkers for Oncology - Advantages &

Disadvantages

01 02 03 04 05 06

Precision Oncology - the road ahead from “vaguely right” to “precisely right”

Computational Epigenetics: Advances and challenges

Precison medince: challenges and future

Improve treatment efficacy and reduce patients side effects, through the optimization of

companion diagnosis

Invent new R&D partnership models to accelerate adoption of

companion diagnostics

How do you optimize CDx assays before you have access to stratified

clinical samples?

Antibody engineering considerations for immuno-oncology

ADC’s: Current challanges and opportuinities

Investments for PoC antibody discovery

Disciplined alliance management as a facilitator of successful global

discovery collaborations

How the Immuno-Oncology Therapies Have Changed the Standard of Care in Oncology

Discovery of ImmunoOncology Therapies: Antibody and Virus-based Approaches

BIOMARKER DISCOVERY PRECISION MEDICINE PERSONALISED MEDICINE COMPANION DIAGNOSTICS ANTIBODY DISCOVERY

IMMUNO-ONCOLOGY CHECK POINT INHIBITORS

Wolfgang Hackl - FounderOncoGenomX

Lore Gruenbaum - VP of Biology Gotham Therapeutics

Fatima Ann Sulaiman - Head of Resrc. Scleroderma and Raynaud’s UK

Zahra Jawad - Group Leader Agenus

Soren Bregenholt - CEOMacrophage Pharma

Achim Kless - Scien. Director Grünenthal Group

Lucy Clossick Thomson - DirectorArchilles Therapeutics

Henry Alistair - Head of Discov. Science UCB

Greet C. Mudde - Founder & CSOS-target Therapeutics

CLINICAL RESEARCH

The clinical trial of the future: will AI and Blockchain be a core part of drug

development?

Sridevi Nagarajan - Sr. Director AstraZeneca

Using RWE to speed the Clinical reserach lifecycle and increase

patient engament

Real time Trials: Genomics & small target population

Aleksandra Filipovic - Therapeutic Lead PureTech Health

Prasun Mishra, Ph.D.- Founder and CEO Agility Pharma, MetaImmune Inc. and

American Association for Precision Medicine

12:00 - 12:30

19:20 - 20:20

14:30 - 15:30

18:00 - 19:00

13:30 - 14:30

19:00 - 19:20

12:30 - 13:30

15:30 - 17:30

17:30 - 18:00

TIME ( *G.M.T. )TRACK & ROOM

7:00 - 7:30

14:20 - 15:20

9:30 - 10:30

13:00 - 14:00

8:30 - 9:30

14:00 - 14:20

7:30 - 8:30

10:30 - 12:30

12:30 - 13:00

TIME ( *E.T. )TRACK & ROOM

NETWORKING BREAK1 - 1 MEETING *13:30-13:50 G.M.T. NETWORKING BREAK

1 - 1 MEETING *19:00-19:20 G.M.T.

1 - 1 MEETING *13:50-14:10 G.M.T. 1 - 1 MEETING *14:10-14:30 G.M.T.

1 - 1 MEETING *15:30-15:50 G.M.T. 1 - 1 MEETING *16:10-16:30 G.M.T. 1 - 1 MEETING *16:50-17:10 G.M.T.1 - 1 MEETING *15:50-16:10 G.M.T. 1 - 1 MEETING *16:30-16:50 G.M.T. 1 - 1 MEETING *17:10-17:30 G.M.T.

Dr. Allan Jordan - Director of Oncology

ONCOLOGY

ONCOLOGY AGENDA

PROVENTAI N T E R N A T I O N A L

3

BIOINFORMATICSBIOINFORMATICS

GO TO MENU NEXT PAGEPREVIOUS PAGE

07 08 09 10 11 12

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

ROUND TABLE TOPIC CONFIRMED FOR SPONSOR

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

ROUNDTABLE TOPIC CONFIRMED FOR SPONSOR

KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION

KEYNOTE PRESENTATION KEYNOTE PRESENTATIONKEYNOTE PRESENTATION

How to Improving Drug Development and Clinical trials with Real World

Evidence

Predictive analytics: The leveraging of computational techniques to aide in

decision-making

Improving the efficiency of Clinical trials with real world data

Strategic partnership of AI start-up and Pharma

Foundational concepts for good design thinking, intelligent adaption

and community adoption

AI in drug discovery: challenges and opportunities

Using data analytics to drive innovation and value

The importance of data integration in Clinical Trials; accessibility to data set for reproducibility and

study expansion

Data integration solution, for the improvement of research

How do we gain mechanistic insights from multi-level data

integration?

Integration, Analysis & Visualisation of Biological Data

Making better informed decisions from visualisation and analytic tools

ML for real world: How can big data bring the future of AI into medicine

Big Data for the development of new crop varieties for the biobased markets

Breaking down barriers to AI adoption in health care

TRANSLATIONAL MEDICINE & INFORMATICS AI & MACHINE LEARNING DATA INTEGRATION & DATA MINING DATA VISUALISATION BIG DATA & DATA MANAGEMENT

Paul Agapow - Health Info. Director AstraZeneca

Steven Zimmer - CEO EPICOMBI Therapeutics Ltd.

Rodrigo Lopez - Head of Web Prod. Wellcome Trust Genobe Campus

Emma Laing - Lead Bioinform. Eli Lilly

Minauti Frost - Vice PresidentGSK

Fred Jacobs - CEOTYG-Oncology

David Hamilton - Associate Director Novartis

Vincent Lawton - ChairmanAddex Therapeutics

David Brown - Head of Infrastruc. Genomics England Ltd.

Alvaro Costa - CEOAlkol Bioteck

Chris Penkett - Head of Pipelines Univ. of Cambridge

Tim Van den Bulcke - Head Bioinfo. Galapagos

Bonde Bhushan - Head of IT Solut. UCB

Marcelo Garcia - Former HeadNovartis

GENOMICS

Design & execution of optimal cross-platform translational medicine programmes to

define in-human mechanism of action and identify

therapeutic biomarkers.Philip Beer - Director

Tessellex Ltd.

Bio-Courier Technology as Non-Viral Delivery System for

Gene Therapy.

Suzanne Saffie-Siebert - CEO SiSaf

The Evolving Landscape of Compute for Genomics

Charles Bradshaw - Head of Bioinf. The Gurdon Institute

12:00 - 12:30

19:20 - 20:20

14:30 - 15:30

18:00 - 19:00

13:30 - 14:30

19:00 - 19:20

12:30 - 13:30

15:30 - 17:30

17:30 - 18:00

TIME ( *G.M.T. )TRACK & ROOM

7:00 - 7:30

14:20 - 15:20

9:30 - 10:30

13:00 - 14:00

8:30 - 9:30

14:00 - 14:20

7:30 - 8:30

10:30 - 12:30

12:30 - 13:00

TIME ( *E.T. )TRACK & ROOM

NETWORKING BREAK1 - 1 MEETING *13:30-13:50 G.M.T. NETWORKING BREAK

1 - 1 MEETING *19:00-19:20 G.M.T.

1 - 1 MEETING *13:50-14:10 G.M.T. 1 - 1 MEETING *14:10-14:30 G.M.T.

1 - 1 MEETING *15:30-15:50 G.M.T. 1 - 1 MEETING *16:10-16:30 G.M.T. 1 - 1 MEETING *16:50-17:10 G.M.T.1 - 1 MEETING *15:50-16:10 G.M.T. 1 - 1 MEETING *16:30-16:50 G.M.T. 1 - 1 MEETING *17:10-17:30 G.M.T.

Hans Constandt - FounderWim Van Criekinge - Co-founder

AGENDA

PROVENTAI N T E R N A T I O N A L

4

ONCOLOGY

Lore Gruenbaum VP of Biology

Gotham Therapeutics

Biomarker discovery and validation: genomics and beyond

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

12:00 - 12:30

Achim KlessScientific DirectorGrünenthal Group

Machine learning informed biomarker selection using multi-omics integration.

ROUNDTABLE TOPIC

TIME SLOT (*GMT)18:00 - 19:00

SPEAKER TBC TBC TBC

Biomarkers in Diagnosis: challenges and approaches.

TIME SLOT (*GMT)

14:30 - 15:30

Extracellular RNA biomarkers for Oncology - Advantages &

Disadvantages

ROUNDTABLE TOPIC

TIME SLOT (*GMT)19:20 - 20:20

SPEAKER TBC TBC TBC

SPONSOR ROUNDTABLE TOPIC

GO TO MENU NEXT PAGEPREVIOUS PAGE

LEARN MORE ABOUT OUR SPEAKERS

TRACK 1 BIOMARKER DISCOVERY

PROVENTAI N T E R N A T I O N A L

5

ONCOLOGY

Wolfgang HacklFounder & CEO OncoGenomX

Precision Oncology - the road ahead from “vaguely right” to

“precisely right”.

Lucy Clossick Thomson Director of Clinical

OperationsAchilles Therapeutics

Computational Epigenetics: Advances and challenges.

SPEAKER TBC TBC TBC

Beginning to leverage OMICS / Beyond genomics: The next wave of

innovation in precision medicine.

Precison medince: challenges and future

Prasun Mishra, Ph.D.Founder and CEO

Agility Pharma, MetaImmune Inc. and American Association for

Precision Medicine

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

TRACK 2 PRECISION MEDICINE / PERSONALISED MEDICINE

PROVENTAI N T E R N A T I O N A L

6

TRACK 3 COMPANION DIAGNOSTICS

ONCOLOGY

Fatima Ann SulaimanHead of Research & Services Scleroderma & Raynaud’s UK

Improve treatment efficacy and reduce patients side effects, through

the optimization of companion diagnosis.

SPEAKER TBC TBC TBC

Invent new R&D partnership models to accelerate adoption of companion

diagnostics.

SPEAKER TBC TBC TBC

Multiplex companion diagnostics – development to commercialisation.

How do you optimize CDx assays before you have access to stratified

clinical samples?SPEAKER TBC

TBC TBC

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

7

TRACK 4 ANTIBODY DISCOVERY

ONCOLOGY

Antibody engineering considerations for immuno-oncology

Henry AlistairHead of Discovery Science

UCB

Zahra JawadGroup Leader in

Discovery TechnologyAgenus

ADC’s: Current challanges and opportuinities

SPEAKER TBC TBC TBC

Engineering Better Antibody Therapeutics Using Computational

Approaches.

Investments for PoC antibody discovery.

SPEAKER TBC TBC TBC

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

8

TRACK 5 IMMUNO-ONCOLOGY / CHECK POINT INHIBITORS

ONCOLOGY

Soren BregenholtCEO

Macrophage Pharma

Disciplined alliance management as a facilitator of successful global

discovery collaborations.

Geert C. MuddeFounder & CSO

TYG Oncology Ltd.

How the Immuno-Oncology Therapies Have Changed the

Standard of Care in Oncology.

SPEAKER TBC TBC TBC

How an integrated drug discovery approach can better support cancer

immunotherapy.

Discovery of ImmunoOncology Therapies: Antibody and Virus-based

Approaches.Aleksandra FilipovicTherapeutic Lead for

Oncology PureTech Health

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

9

TRACK 6 CLINICAL RESEARCH

ONCOLOGY

Sridevi Nagarajan Senior Director,

Knowledge Management AstraZeneca

The clinical trial of the future: will AI and Blockchain be a core part

of drug development?

SPEAKER TBC TBC TBC

Using RWE to speed the Clinical reserach lifecycle and increase

patient engament

SPEAKER TBC TBC TBC

Liquid Biopsies in Oncology Clinical Trials: Present and Future

Real time Trials: Genomics and small target

population.SPEAKER TBC

TBC TBC

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

10

BIOINFORMATICS

TRACK 7 GENOMICS

Philip BeerDirector

Tessellex Ltd.

Design and execution of optimal cross-platform translational

medicine programmes to define in-human mechanism of action and

identify therapeutic biomarkers.

Charles BradshawHead of Bioinformatics Core

The Gurdon InstituteUniversity of Cambridge

What can pharmaceutical R&D executives do to successfully lead

human genetics enabled R&D organizations?

Prof. Wim Van CriekingeCo-Founder BioLIzard

Next generation biomarkers: from omics to precision medicine

Bio-Courier Technology as Non-Viral Delivery System for Gene Therapy.

Suzanne Saffie-Siebert CEO

SiSaf Ltd.

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

11

TRACK 8 TRANSLATIONAL MEDICINE & INFORMATICS

BIOINFORMATICS

Paul Agapow Health Informatics Director

AstraZeneca

How to Improve Drug Development and Clinical trials with Real World

Evidence.

Fred Jacobs CEO

TYG-Oncology

Predictive analytics: The leveraging of computational techniques to aide

in decision-making.

SPEAKER TBC TBC TBC

Data Science for translational research in Pharmaceutical industry.

Improving the efficiency of Clinical trials with real world data.

Chris Penkett Head of Pipelines NHSBTUniversity of Cambridge

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

12

TRACK 9 ARTIFICIAL INTELLIGENCE / MACHINE LEARNING

BIOINFORMATICS

Steven Zimmer CEO

EPICOMBI Therapeutics Ltd.

Strategic partnership of AI startup and Pharma.

David Hamilton Associate Director, Clinical Development & Analytics

Novartis

Foundational concepts for good design thinking, intelligent adaption

and community adoption

SPEAKER TBC TBC TBC

AI in drug discovery: challenges and opportunities.

Tim Van den BulckeHead of Bioinformatics

Galapagos

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

Using AI and Machine Learning to reduce time and increse the

productivity of drug discovery

PROVENTAI N T E R N A T I O N A L

13

TRACK 10 DATA INTEGRATION / DATA MINING

BIOINFORMATICS

Rodrigo Lopez Head of Web Prod.

Wellcome Trust Genome Campus

Using data analytics to drive innovation and value.

Vincent Lawton Chairman & CEO

Addex Therapeutics

The importance of data integration in Clinical Trials; accessibility to data

set for reproducibility and study expansion.

Hans ConstandtFounder

Ontoforce

How to integrate data into one consistent, accessible environment to

improve data quality and efficency.

Data integration solution, for the improvement of research.

Bonde Bhushan Head of IT-Eearly Solutions Innovation Development

UCB

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

14

TRACK 11 DATA VISUALISATION

BIOINFORMATICS

Emma Laing Lead Bioinformatician

Eli Lilly

Bioimaging data analysis in disease diagnosis and data visualization in

large-scale biodata.

David Brown Head of Infrastructure

Genomics England Ltd.

Integration, Analysis and Visualisation of Biological Data.

SPEAKER TBC TBC TBC

How visualisation and analysis tools can better support R&D decision

making.

Making better informed decisions from visualisation and analytic tools.

SPEAKER TBC TBC TBC

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

15

TRACK 12 BIG DATA / DATA MANAGEMENT

BIOINFORMATICS

Minauti Frost VP Digital Risk

GSK

M-L for real world: How can big data bring the future of AI into medicine.

Alvaro Costa CEO

Alkol Biotech

Big Data for the development of new crop varieties for the biobased

markets.

SPEAKER TBC TBC TBC

How to streamline and structure big data to build machine learning

models.

Breaking down barriers to AI adoption in health care.

Marcelo Garcia Former Medical Systems Head

Novartis

GO TO MENU NEXT PAGEPREVIOUS PAGE

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

TIME SLOT (*GMT)

ROUNDTABLE TOPIC

TIME SLOT (*GMT)

SPONSOR ROUNDTABLE TOPIC

12:00 - 12:30

18:00 - 19:00

14:30 - 15:30

19:20 - 20:20LEARN MORE ABOUT OUR SPEAKERS

PROVENTAI N T E R N A T I O N A L

16

2019 ATTENDEES p.1

GO TO MENU NEXT PAGEPREVIOUS PAGE

COMPANYABPIAIT Austrian Institute of Technology GmbHAlkol BiotechAmgenAmgenAmgenArtios PharmaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaAstraZenecaBar Ilan UniversityBayer AGBiogenBiogenBiomedical Research Centre at Guy’s Hospital and King’s College LondonBiozentrum, University of BaselBluebird bioBlueprint MedicinesBoehringer Ingelheim Bridge Biotec LtdBrunel University LondonC4x DiscoveryC4x Discovery Coordination Centre for Clinical Trials (KKS)Debiopharm InternationalE Therapeutics PLCEli LillyEli LillyErasmus MCeTherapeuticsFraunhofer ITEM GalapagosGenomics EnglandGlaxoSmithKlineGlaxoSmithKline

JOB TITLE

Head of Health Data & OutcomesThematic CoordinatorCEOEuropean RWD leadProgramming Lead for Europe, Centre for Observational ResearchDirectorPrincipal Scientist, BioinformaticsGlobal Head of Health InformaticsHealth Informatics DirectorPrincipal ScientistPrincipal Data ScientistSenior Director, Knowledge ManagementAssociate Director, BioinformaticsAssociate Principal Informatics ScientistProgramme Manager, Clinical Information SharingProfessor/Director Clinical Development LeadHead of Computational ChemistryMedical Director, EU & Canada Medical Strategy & Execution LeadHead of Genomics Research Platform and Single Cell Facility and Senior Research FellowHead Research ITAssociate Director Medical AffairsInternational Head of Precision MedicineClinical Program LeadDirector / CEOSenior LecturerTarget Discovery Genetics Project LeaderVP Novel Target Biology & GenomicsDirectorVP Translational MedicineBusiness Development and Programme DirectorLead Senior BioinformaticianSenior BioinformaticianProfessorPrincipal Data ScientistGroup LeaderHead of BioinformaticsHead of Bioinformatics PartnershipsGlobal Head Computational Biology and Stats Scientific Leader

Glenmark PharmaceuticalsGoldsmiths, University of LondonGrünenthalGSKGSKGSKGSKGSKHiFiBioImmatics BiotechImperial College LondonImperial College LondonInflaRx InflaRxIO BiotechiOnctura SA IpsenIpsenJanssenJuno Therapeutics, a Celgene companyKarus TherapeuticsKing’s College LondonKymabLeo PharmaLondon South Bank UniversityMax Planck Institute for Biology of AgeingMedigene Immunotherapies GmbHMedImmuneMerckMerck KGaAMerck KGaAMerck KGaAMerck KGaAMerck Sharp & DohmeMerusMolecular Partners, AGMorphoSysMorphoSysNanna Therapeutics

Senior Vice President, Global Head of Translational SciencesProfessor of Cognitive ComputingScientific Director Senior Scientific DirectorSenior MetaData ManagerInterim Head of Human Genetics Computational BiologySenior MetaData ExpertScience Advisor Gene Therapy and Rare DiseaseEVP Business DevelopmentDirector, Clinical DevelopmentResearch FellowProfessor/ Director CISBIOCMOProgram Director Clinical Research & Development OncologyChief Medical OfficerChief Operating OfficerVice President Translational Sciences & Clinical Pharmacology Medical DirectorMedical Manager OncologySenior Vice President and Managing DirectorChief Operating Officer and Chief Scientific OfficerDirector of eResearchSenior Scientist (KY1005 Scientific Lead) , Transnational MedicinePrincipal ScientistProfessor, Head of Big Data and Informatics Research GroupHead of BioinformaticsDirectorVP Clinical RespiratoryDirector Cancer & Inflammation, Scientific Site Head Immuno-OncologyDirector Oncology BioinformaticsMarket Access Lead Oncology EMEADirector, Clinical Quality ManagementSenior Director, Head Biomarker Development & Validation StrategyDirector, R&D Analytics Executive Vice President and Chief Scientific OfficerVP, Head of Immuno-oncologyDirector, Program LeaderVice President & Head of CommercialDirector of Informatics

COMPANY JOB TITLE

BIOINFORMATICSBIOINFORMATICSONCOLOGY

ONCOLOGY &

PROVENTAI N T E R N A T I O N A L

17

2019 ATTENDEES p.2

GO TO MENUPREVIOUS PAGE

COMPANY

Nektar TherapeuticsNeovii Pharmaceuticals NovartisNovartis“Novartis “NovozymesOncoOneOncoQR MLOxford BioTherapeuticsOxford BioTherapeuticsPhilochemPierisPierre FabreProthenaQueen Mary UniversityRocheRocheRocheRocheRoche Roche Roche DiagnosticsRoche PharmaSandoz International

JOB TITLE

Vice President and Head of DiscoveryChief Scientific OfficerData Science Head MusculoskeletalHead of Medical Affairs OREMedical Systems Head - ICE, Global Medical AffairsHead of IT DepartmentCEOChief Scientific Officer and Managing DirectorDirector of Information Systems and BioinformaticsChief Executive OfficerGlobal Head of Precision MedicineDirector Immuno OncologyVice President – Head of Translational MedicineEU Medical Affairs headProfessor and Director, Centre for Translational Bioinformatics Global Head Strategic Alliances PREDiHead of Global BI Solution Center WelwynDigital Lead for Large Molecule ResearchDirector External Innovation, Oncology DiscoveryGlobal Medical DirectorGlobal Studies LeaderHead Data ManagementSenior LeaderHead Strategy and Novartis Collaborations

Sanofi

SanofiServierServierServier Deutschland GmbH ShireTakedaThemis BiosciencesTYG OncologyUCBUCBUCBUCLUniversität zu Lübeck, Medical Systems BiologyUniversity College LondonUniversity of BaselUniversity of BuckinghamUniversity of CambridgeUniversity of Halle-WittenbergUniversity of Leipzig University of LübeckUniversity of MunichUniversity of PlymouthVertex Pharmaceuticals

Sr Director, European Head of Medical Affairs for Oncology, Hematology and Solid Organ TransplantationMedical Manager Oncology GSAHead of Bioinformatics and Computational BiologyHead of Global Oncology Early Products StrategyDirector BU Oncology / HematologyGlobal Medical LeadScientific Informatics ArchitectHead ImmunotherapyChief Executive Officer and Co-Founder Director, Translational Bioinformatics, NeurosciencesHead of IT, New Medicines Innovation Senior Data Acquisition ManagerAcademic Lead of UCL GenomicsGroup LeaderProfessor of Bioinformatics and Computational BiologyProject HeadInterim Dean – School of ComputingHead of Bioinformatics CoreGroup LeaderDeputy HeadProfessor for Systems MedicinePrivate ProfessorProfessor in BioinformaticsDirector, Scientific Computing

COMPANY JOB TITLE

BIOINFORMATICSBIOINFORMATICSONCOLOGY

ONCOLOGY &